Comparison of IL-8, IL-6 and PGE2 formation by visceral (omental) adipose tissue of obese caucasian compared to African-American women

Obesity Surgery

Volumn 16, Issue 10, 2006, Pages 1342-1350

  Madan, Atul K ^a,b   Tichansky, David S ^a   Coday, Mace ^a   Fain, John N ^a  

^a UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Adiponectin; COX 2; Depression; Ethnicity; Human adipose tissue; IL 6; IL 8; Morbid obesity; Obesity; PGE2

Indexed keywords

CYCLOOXYGENASE 2; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; PROSTAGLANDIN E2;

ADIPOSE TISSUE; ADULT; AFRICAN AMERICAN; ARTICLE; BARIATRIC SURGERY; CAUCASIAN; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; FEMALE; HUMAN; IN VITRO STUDY; LIPID ANALYSIS; OBESITY; OMENTUM; PRIORITY JOURNAL;

ABDOMINAL FAT; ADIPONECTIN; ADULT; AFRICAN AMERICANS; BODY MASS INDEX; DEPRESSION; DINOPROSTONE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; OBESITY, MORBID; RNA, MESSENGER; SOCIAL CLASS;

EID: 33750570443     PISSN: 09608923     EISSN: None     Source Type: Journal    
DOI: 10.1381/096089206778663652     Document Type: Article

References (55)

1. Engelgau MM, Geiss LS, Saaddine JB et al. The evolving diabetes burden in the United States. Ann Intern Med 2004; 140: 945-51.
2. Glover MJ, Greenlund KJ, Ayala C et al. Racial/ethnic disparities in prevalence, treatment, and control of hypertension - United States, 1999-2002. MMWR 2005; 54: 7-9.
3. Sugerman HJ, Wolfe LG, Sica DA. Diabetes and hypertension in severe obesity and effects of gastric bypass-induced weight loss. Ann Surg 2003; 237: 751-6.
4. Calle EE, Thun MJ, Petrelli JM et al. Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 1999; 341: 1097-105.
5. Livingston EH, Ko CY. Effect of diabetes and hypertension on obesity-related and mortality. Surgery 2005; 137: 16-25.
6. Buffington CK, Marema RT. Ethnic differences in obesity and surgical weight loss between African-American and Caucasian females. Obes Surg 2006; 16: 159-65.
7. DeMaria EJ, Sugerman HJ, Meador JG et al. High failure rate after laparoscopic adjustable silicone gastric banding for treatment of morbid obesity. Ann Surg 2001; 233: 809-18.
8. Capella RF, Capella JF. Ethnicity, type of obesity surgery and weight loss. Obes Surg 1993; 3: 375-80.
9. Kahn HS, Williamson DF, Stevens JA. Race and weight change in US women: the role of socioeconomic and marital status. Am J Public Health 1991; 81: 319-23.
10. Kumanyika SK, E Obarzanek, Stevens VJ et al. Weight-loss experience of black and white participants in NHLBI-sponsored clinical trials. Am J Clin Nutr 1991; 53: 1631S-1638S.
11. Wing RR, Anglin K. Effectiveness of a behavioral weight control program for blacks and whites with NIDDM. Diabetes Care 1996; 19: 409-13.
12. Bower JF, Deshaies Y, Pfeifer M et al. Ethnic differences in postprandial triglyceride response to a fatty meal and lipoprotein lipase in lean and obese African American and Caucasian women. Metabolism 2002; 51: 211-7.
13. Bower JF, Vadlamudi S, Barakat HA. Ethnic differences in in vitro glyceride synthesis in subcutaneous and omental adipose tissue. Am J Physiol Endocrinol Metab 2002; 283: 988-93.
14. Burke GL, Sprafka JM, Folsom AR et al. Trends in CHD mortality, morbidity and risk factor levels from 1960 to 1986: the Minnesota Heart Survey. Int J Epidemiol 1989; 18: 73-81.
15. Privette JD, Hickner RC, MacDonald KG et al. Fatty acid oxidation by skeletal muscle homogenates from morbidly obese black and white American women. Metabolism 2003; 52: 735-8.
16. Stevens J, Kumanyika SK, Keil JE. Attitudes toward body size and dieting: differences between elderly black and white women. Am J Public Health 2004; 84: 1322-5.
17. Tanner CJ, Barakat HA, Dohm GL et al. Muscle fiber type is associated with obesity and weight loss Am J Physiol Endocrinol Metab 2002; 282: E1191-E1196.
18. Yusuf S, Hawken S, Ounpuu S et al. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet 2005; 366: 1640-9.
19. Houston DK, Stevens J, Cai J. Abdominal fat distribution and functional limitations and disability in a biracial cohort: the atherosclerosis risk in communities study. Int J Obes 2005; 29: 1457-63.
20. 2, prostacyclin and leptin release by human adipocytes versus explants of adipose tissue in primary culture. Prostaglandins Leukot Essent Fatty Acids 2002; 67: 467-73.
21. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-9.
22. Degawa-Yamauchi M, Dilts JR, Bovenkerk JE et al. Lower serum adiponectin levels in African-American boys. Obes Res 2003; 11: 1384-90.
23. Hulver MW, Saleh O, MacDonald KG et al. Ethnic differences in adiponectin levels. Metabolism 2004; 53: 1-3.
24. Pouliot MC, Despres JP, Lemieux S et al. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol 1994; 73: 460-8.
25. Despres JP, Couillard C, Gagnon J et al. Race, visceral adipose tissue, plasma lipids, and lipoprotein lipase activity in men and women: the health, risk factors, exercise training, and genetics (HERITAGE) family study. Arterioscler Thromb Vasc Biol 2000; 20: 1932-8.
26. Lovejoy JC, Bretonne JA, Klemperer M et al. Abdominal fat distribution and metabolic risk factors: effects of race. Metabolism 1996; 45: 1119-124.
27. Albu JB, Murphy L, Frager DH et al. Visceral fat and race-dependent health risk in obese nondiabetic premenopausal women. Diabetes 1997; 46: 456-62.
28. Cottam DR, Mattar SG, Barinas-Mitchell E et al. The chronic inflammatory hypothesis for the morbidity associated with morbid obesity: implications and effects of weight loss. Obes Surg 2004; 14: 589-600.
29. Trayhurn P. Endocrine and signalling role of adipose tissue: new perspectives on fat. Acta Physiol Scand 2005; 184: 285-93.
30. Hauner H. Secretory factors from human adipose tissue and their functional role. Proc Nutr Soc 2005; 64: 163-9.
31. Berg AH, Scherer PE. Adipose tissue, inflammation, and cardiovascular disease. Circ Res 2005; 96: 939-49.
32. Yudkin JS, Kumari M, Humphries SE et al. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis 2000; 148: 209-14.
33. Mohamed-Ali V, Goodrick S, Rawesh A et al. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vito. J Clin Endocrinol Metab 1997; 82: 4196-200.
34. Orban A, Remaley AT, Sampson M et al. The differential effect of food intake and beta-adrenergic stimulation on adipose-derived hormones and cytokines in man. J Clin Endocrinol Metab 1999; 84: 2126-33.
35. Bastard JP, Jardel C, Bruckert E et al. Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. J Clin Endocrinol Metab 2000; 85: 3338-342.
36. Kern PA, Ranganathan S, Li C et al. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab 2001; 280: E745-751.
37. Reape TJ, Groot PH. Chemokines and atherosclerosis. Atherosclerosis 1999; 147: 213-25.
38. Xu H, Barnes GT, Yang Q et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003; 112: 1821-30.
39. Weisberg SP, McCann D, Desai M et al. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003; 112: 1796-1808.
40. Bruun JM, Verdich C, Toubro S et al. Association between measures of insulin sensitivity and circulating levels of interleukin-8, interleukin-6 and tumor necrosis factor-alpha. Effect of weight loss in obese men. Eur J Endocrinol 2003; 148: 535-42.
41. Straczkowski M, Dzienis-Straczkowska S, Stepien A et al. Plasma interleukin-8 concentrations are increased in obese subjects and related to fat mass and tumor necrosis factor-alpha system. J Clin Endocrinol Metab 2002; 87: 4602-6.
42. Boekholdt SM, Peters RJG, Hack CE et al. IL-8 plasma concentrations and the risk of future coronary artery disease in apparently healthy men and women. The EPIC-Norfolk prospective population study. Arterioscler Thromb Vasc Biol 2004; 24: 1503-8.
43. Manigrasso MR, Ferroni P, Santilli F et al. Association between circulating adiponectin and interleukin-10 levels in android obesity: effects of weight loss. J Clin Endocrinol Metab 2005; 90: 5876-9.
44. Fain JN, Bahouth SW, Madan AK. Involvement of multiple signaling pathways in the post-bariatric induction of IL-6 and IL-8 mRNA and release in human visceral adipose tissue. Biochem Pharmacol 2005; 69: 1315-24.
45. Brancati FL, Kao WH, Folsom AR et al. Incident type 2 diabetes mellitus in African American and white adults: the atherosclerosis risk in communities study. JAMA 2000; 284: 2318-9.
46. Dagogo-Jack S. Ethnic disparities in type 2 diabetes: pathophysiology and implications for prevention and management. J Natl Med Assoc 2003; 95: 774, 779-89.
47. Residori L, Garcia-Lorda P, Flancbaum L et al. Prevalence of co-morbidities in obese patients before bariatric surgery: effect of race. Obes Surg 2003; 13: 333-40.
48. Blazer DG, Hybels CF, Simonsick EM et al. Marked differences in antidepressant use by race in an elderly community sample: 1986-1996. Am J Psychiatry 2000; 157: 1089-94.
49. Onyike CU, Crum RM, Lee HB et al. Is obesity associated with major depression? Results from the third National Health and Nutrition examination survey. Am J Epidemiol 2003; 158: 1139-47.
50. Cooper LA, Gonzales JJ, Gallo JJ et al. The acceptability of treatment for depression among African-American, Hispanic, and white primary care patients. Med Care 2003; 41: 479-89.
51. Harman JS, Edlund MJ, Fortney JC. Disparities in the adequacy of depression treatment in the United States. Psychiatr Serv 2004; 55: 1379-85.
52. Miller DK, Malmstrom TK, Joshi S et al. Clinically relevant levels of depressive symptoms in community-dwelling middle-aged African Americans. J Am Geriatr Soc 2004; 52: 741-8.
53. Dong C, Sanchez LE, Price RA. Relationship of obesity to depression: a family-based study. Int J Obes 2004; 28: 790-5.
54. Kales HC, Neighbors HW, Valenstein M et al. Effect of race and sex on primary care physicians' diagnosis and treatment of late-life depression. J Am Geriatr Soc 2005; 53: 777-84.
55. Skaer TL, Sclar DA, Robison LM et al. Trends in the rate of depressive illness and use of antidepressant pharmacotherapy by ethnicity/race: an assessment of office-based visits in the United States, 1992-1997. Clin Ther 2000; 22: 1575-89.